These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19126779)

  • 1. Functional SNPs in the SCGB3A2 promoter are associated with susceptibility to Graves' disease.
    Song HD; Liang J; Shi JY; Zhao SX; Liu Z; Zhao JJ; Peng YD; Gao GQ; Tao J; Pan CM; Shao L; Cheng F; Wang Y; Yuan GY; Xu C; Han B; Huang W; Chu X; Chen Y; Sheng Y; Li RY; Su Q; Gao L; Jia WP; Jin L; Chen MD; Chen SJ; Chen Z; Chen JL
    Hum Mol Genet; 2009 Mar; 18(6):1156-70. PubMed ID: 19126779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.
    Gu LQ; Zhu W; Zhao SX; Zhao L; Zhang MJ; Cui B; Song HD; Ning G; Zhao YJ
    Clin Endocrinol (Oxf); 2010 Feb; 72(2):248-55. PubMed ID: 19438904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmation of association of chromosome 5q31-33 with United Kingdom Caucasian Graves' disease.
    Simmonds MJ; Yesmin K; Newby PR; Brand OJ; Franklyn JA; Gough SC
    Thyroid; 2010 Apr; 20(4):413-7. PubMed ID: 20210668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The -112G>A polymorphism of the secretoglobin 3A2 (SCGB3A2) gene encoding uteroglobin-related protein 1 (UGRP1) increases risk for the development of Graves' disease in subsets of patients with elevated levels of immunoglobulin E.
    Chistiakov DA; Voronova NV; Turakulov RI; Savost'anov KV
    J Appl Genet; 2011 May; 52(2):201-7. PubMed ID: 21170691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of SNPs at 18 positional candidate genes, located within the GD-1 locus on chromosome 14q23-q32, for susceptibility to Graves' disease: a TDT study.
    Chistiakov DA; Savost'anov KV; Turakulov RI
    Mol Genet Metab; 2004 Nov; 83(3):264-70. PubMed ID: 15542398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in the interleukin 3 gene show strong association with susceptibility to Graves' disease in Chinese population.
    Chu X; Dong C; Lei R; Sun L; Wang Z; Dong Y; Shen M; Wang Y; Wang B; Zhang K; Yang L; Li Y; Yuan W; Wang Y; Song H; Jin L; Xiong M; Huang W
    Genes Immun; 2009 Apr; 10(3):260-6. PubMed ID: 19262575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Tag single nucleotide polymorphisms (SNPs) to screen PTPN21: no association with Graves' disease.
    Zeitlin AA; Heward JM; Brand OJ; Newby PR; Franklyn JA; Gough SC; Simmonds MJ
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):380-4. PubMed ID: 16918960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the interleukin (IL)-16 gene polymorphisms with Graves' disease.
    Gu XJ; Cui B; Zhao ZF; Chen HY; Li XY; Wang S; Ning G; Zhao YJ
    Clin Immunol; 2008 Jun; 127(3):298-302. PubMed ID: 18394967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The common variants of E-selectin gene in Graves' disease.
    Chen H; Cui B; Wang S; Zhao Z; Sun H; Gu X; Zhao Y; Li X; Ning G
    Genes Immun; 2008 Mar; 9(2):182-6. PubMed ID: 18094708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary study on the association of chemokine RANTES gene polymorphisms with HIV-1 infection in Chinese Han population].
    Liu XL; Wang FS; Jin L; Liu MX; Xu DZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):971-5. PubMed ID: 14687494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association and linkage studies of the 20q11.2 region (GRD-2 locus) with Graves' disease in the Tunisian population.
    Makni K; Hadj Kacem H; Rebaï A; Abid M; Ayadi H
    Ann Hum Biol; 2007; 34(5):566-72. PubMed ID: 17786592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.
    Kurylowicz A; Hiromatsu Y; Jurecka-Lubieniecka B; Kula D; Kowalska M; Ichimura M; Koga H; Kaku H; Bar-Andziak E; Nauman J; Jarzab B; Ploski R; Bednarczuk T
    Genes Immun; 2007 Oct; 8(7):532-8. PubMed ID: 17690684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of FcGRIIa with Graves' disease: a potential role for dysregulated autoantibody clearance in disease onset/progression.
    Yesmin K; Hargreaves C; Newby PR; Brand OJ; Heward JM; Franklyn JA; Gough SC; Simmonds MJ
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):119-25. PubMed ID: 20148910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between interleukin 21 and Graves' disease.
    Jia HY; Zhang ZG; Gu XJ; Guo T; Cui B; Ning G; Zhao YJ
    Genet Mol Res; 2011 Oct; 10(4):3338-46. PubMed ID: 22057994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of the HCR gene and a genomic segment in close proximity to HLA-C are associated with patients with psoriasis in Taiwan.
    Chang YT; Shiao YM; Chin PJ; Liu YL; Chou FC; Wu S; Lin YF; Li LH; Lin MW; Liu HN; Tsai SF
    Br J Dermatol; 2004 Jun; 150(6):1104-11. PubMed ID: 15214895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression.
    Jacobson EM; Huber AK; Akeno N; Sivak M; Li CW; Concepcion E; Ho K; Tomer Y
    Genes Immun; 2007 Apr; 8(3):205-14. PubMed ID: 17344890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer.
    Zhang X; Miao X; Tan W; Ning B; Liu Z; Hong Y; Song W; Guo Y; Zhang X; Shen Y; Qiang B; Kadlubar FF; Lin D
    Gastroenterology; 2005 Aug; 129(2):565-76. PubMed ID: 16083713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.
    Skórka A; Bednarczuk T; Bar-Andziak E; Nauman J; Ploski R
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):679-82. PubMed ID: 15943829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA4 polymorphisms and ophthalmopathy in Graves' disease patients: association study and meta-analysis.
    Han S; Zhang S; Zhang W; Li R; Li Y; Wang Z; Xie Y; Mao Y
    Hum Immunol; 2006 Aug; 67(8):618-26. PubMed ID: 16916658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis and functional evaluation of the C/T(-318) and A/G(-1661) polymorphisms of the CTLA-4 gene in patients affected with Graves' disease.
    Chistiakov DA; Savost'anov KV; Turakulov RI; Efremov IA; Demurov LM
    Clin Immunol; 2006; 118(2-3):233-42. PubMed ID: 16297665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.